These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 8149466

  • 1. A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes.
    Lim CK, Yuan ZX, Lamb JH, White IN, De Matteis F, Smith LL.
    Carcinogenesis; 1994 Apr; 15(4):589-93. PubMed ID: 8149466
    [Abstract] [Full Text] [Related]

  • 2. On-line high-performance liquid chromatographic-electrospray ionization mass spectrometric method for the study of tamoxifen metabolism.
    Jones RM, Yuan ZX, Lamb JH, Lim CK.
    J Chromatogr A; 1996 Jan 26; 722(1-2):249-55. PubMed ID: 9019299
    [Abstract] [Full Text] [Related]

  • 3. Tamoxifen metabolism in rat liver microsomes: identification of a dimeric metabolite derived from free radical intermediates by liquid chromatography/mass spectrometry.
    Jones RM, Yuan ZX, Lim CK.
    Rapid Commun Mass Spectrom; 1999 Jan 26; 13(4):211-5. PubMed ID: 10097399
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The deuterium isotope effect for the alpha-hydroxylation of tamoxifen by rat liver microsomes accounts for the reduced genotoxicity of [D5-ethyl]tamoxifen.
    Jarman M, Poon GK, Rowlands MG, Grimshaw RM, Horton MN, Potter GA, McCague R.
    Carcinogenesis; 1995 Apr 26; 16(4):683-8. PubMed ID: 7728943
    [Abstract] [Full Text] [Related]

  • 6. Evidence that the catechol 3,4-Dihydroxytamoxifen is a proximate intermediate to the reactive species binding covalently to proteins.
    Dehal SS, Kupfer D.
    Cancer Res; 1996 Mar 15; 56(6):1283-90. PubMed ID: 8640815
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of inhibitors on the biotransformation of tamoxifen by female rat and mouse liver slices and homogenates.
    Jordan CG, Brown K, Beedham C, Brown JE.
    Drug Metabol Drug Interact; 1999 Mar 15; 15(4):239-58. PubMed ID: 10716039
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Some chemical and biochemical aspects of liver microsomal metabolism of tamoxifen.
    Ruenitz PC, Bagley JR, Pape CW.
    Drug Metab Dispos; 1984 Mar 15; 12(4):478-83. PubMed ID: 6148216
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient.
    Robinson SP, Langan-Fahey SM, Johnson DA, Jordan VC.
    Drug Metab Dispos; 1991 Mar 15; 19(1):36-43. PubMed ID: 1673419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.